Clorox's Earnings Beat Fails to Lift Shares as Trading Volume Ranks 368th in 52-Week Lows

Generated by AI AgentAinvest Volume Radar
Thursday, Aug 28, 2025 7:03 pm ET1min read
CLX--
Aime RobotAime Summary

- Clorox shares fell 0.49% post-earnings despite a 29.86% EPS beat and $2B revenue, closing near 52-week lows.

- Trading volume of $270M ranked 368th, reflecting ongoing market struggles amid sector-wide demand shifts and supply chain issues.

- The stock trades at 18x P/E below fair value, with a 25.35% annual decline and 4.17% dividend yield sustaining income investors.

- Analysts focus on cost management and strategic adjustments as potential recovery drivers in a profit-margin pressured sector.

On August 28, 2025, CloroxCLX-- (CLX) traded with a volume of $0.27 billion, ranking 368th among active stocks. The consumer goods giant closed below its 52-week low at $117.33, reflecting persistent market challenges despite a 29.86% earnings-per-share (EPS) beat in its latest quarter. The company reported $2.87 EPS against expectations of $2.21, while revenue reached $2 billion, exceeding forecasts by $60 million.

Clorox’s stock, currently valued at $14.36 billion, trades at a price-to-earnings ratio of 18x, below its estimated fair value. The decline follows a year-long 25.35% drop in share price amid sector-wide volatility driven by shifting consumer demand and supply chain disruptions. However, the firm’s 4.17% dividend yield and 48 consecutive years of dividend growth remain key highlights for income-focused investors.

Despite outperforming financial expectations, Clorox’s shares fell 0.49% in after-hours trading to $126.18. Analysts are scrutinizing the company’s strategic adjustments and cost management efforts as potential catalysts for recovery. The mixed performance underscores the sector’s struggle to balance profitability with macroeconomic headwinds.

Query limit exceeded.

Hunt down the stocks with explosive trading volume.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet